View in EDS HTML Full Text PDF Full Text

A Mechanistic Pharmacokinetic/Pharmacodynamic Model for Sequence-Dependent Synergy in Pemetrexed–Osimertinib Combinations Against Non-Small Cell Lung Cancer (NSCLC): Translational Insights.

Saved in:

Bibliographic Details
Title:	A Mechanistic Pharmacokinetic/Pharmacodynamic Model for Sequence-Dependent Synergy in Pemetrexed–Osimertinib Combinations Against Non-Small Cell Lung Cancer (NSCLC): Translational Insights.
Authors:	Hu, Kuan¹ (AUTHOR), Lin, Yan¹ (AUTHOR), Ji, Huachun¹ (AUTHOR), Yuan, Tong¹ (AUTHOR), Xia, Yu¹ (AUTHOR), Yang, Jin¹ (AUTHOR) cpu_yj@163.com
Source:	Pharmaceutics. Apr2026, Vol. 18 Issue 4, p408. 31p.
Database:	Academic Search Ultimate
Full text is not displayed to guests. Login for full access.

Description
ISSN:	19994923
DOI:	10.3390/pharmaceutics18040408